Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Pulmonary Hypertension

Free Subscription 22.07.2019 1 Acta Pharmacol Sin 1 Am J Physiol Lung Cell Mol Physiol 1 BMC Anesthesiol 1 Can J Physiol Pharmacol 1 Clin Genet 2 Eur Respir J 1 Heliyon 2 Herz 2 Int J Cardiol 1 Int J Mol Sci 1 J Am Coll Cardiol 1 J Card Fail 1 J Geriatr Cardiol 1 J Heart Lung Transplant 1 J Lung Health Dis 1 J Perinatol 1 Kardiologiia 1 Mediators Inflamm 1 Medicina (Kaunas) 1 Mol Med Rep

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Pharmacol Sin

1. LI Y, Yang L, Dong L, Yang ZW, et al
   Crosstalk between the Akt/mTORC1 and NF-kappaB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs.
   Acta Pharmacol Sin. 2019 Jul 17. pii: 10.1038/s41401-019-0272.
   PubMed     Text format     Abstract available
   
   

   
   Am J Physiol Lung Cell Mol Physiol

2. LACHANT D, Meoli DF, Haight D, Staicu S, et al
   Combination Therapy Improves Vascular Volume in Female Rats with Pulmonary Hypertension.
   Am J Physiol Lung Cell Mol Physiol. 2019 Jul 19. doi: 10.1152/ajplung.00450.2018
   PubMed     Text format     Abstract available
   
   

   
   BMC Anesthesiol

3. PEARCE B, Hu R, Desmond F, Banyasz D, et al
   Intraoperative TOE guided management of newly diagnosed severe tricuspid regurgitation and pulmonary hypertension during orthotopic liver transplantation: a case report demonstrating the importance of reversibility as a favorable prognostic factor.
   BMC Anesthesiol. 2019;19:128.
   PubMed     Text format     Abstract available
   
   

   
   Can J Physiol Pharmacol

4. ZHANG Q, Zucco L, Toshner M, Morrell NW, et al
   Myeloid angiogenic cells exhibit impaired migration, reduced expression of endothelial markers, and increased apoptosis in idiopathic pulmonary arterial hypertension (1).
   Can J Physiol Pharmacol. 2019;97:306-312.
   PubMed     Text format     Abstract available
   
   

   
   Clin Genet

5. KAROLAK JA, Szafranski P, Kilner D, Patel C, et al
   Heterozygous CTNNB1 and TBX4 variants in a patient with abnormal lung growth, pulmonary hypertension, microcephaly, and spasticity.
   Clin Genet. 2019 Jul 16. doi: 10.1111/cge.13605.
   PubMed     Text format     Abstract available
   
   

   
   Eur Respir J

6. ABID S, Marcos E, Parpaleix A, Amsellem V, et al
   CCR2/CCR5-Mediated Macrophage-Smooth Muscle Cell Crosstalk in Pulmonary Hypertension.
   Eur Respir J. 2019 Jul 18. pii: 13993003.02308-2018.
   PubMed     Text format     Abstract available
   
   
7. HUITEMA MP, Bakker ALM, Mager JJ, Rensing BJWM, et al
   Prevalence of pulmonary hypertension in pulmonary sarcoidosis; the first large European prospective study.
   Eur Respir J. 2019 Jul 18. pii: 13993003.00897-2019.
   PubMed     Text format    
   
   

   
   Heliyon

8. CARVALHO CG, Bresler R, Zhi YX, Alshaer H, et al
   Heart rate variability in pulmonary hypertension with and without sleep apnea.
   Heliyon. 2019;5:e02034.
   PubMed     Text format     Abstract available
   
   

   
   Herz

9. ROSENKRANZ S, Kramer T, Gerhardt F, Opitz C, et al
   Pulmonary hypertension in HFpEF and HFrEF: Pathophysiology, diagnosis, treatment approaches.
   Herz. 2019 Jul 17. pii: 10.1007/s00059-019-4831.
   PubMed     Text format     Abstract available
   
   
10. TICHELBACKER T, Dumitrescu D, Gerhardt F, Stern D, et al
    Pulmonary hypertension and valvular heart disease.
    Herz. 2019 Jul 16. pii: 10.1007/s00059-019-4823.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cardiol

11. DEL POZO R, Blanco I, Hernandez-Gonzalez I, Lopez-Meseguer M, et al
    Real-life experience of inhaled iloprost for patients with pulmonary arterial hypertension: Insights from the Spanish REHAP registry.
    Int J Cardiol. 2019;275:158-164.
    PubMed     Text format     Abstract available
    
    
12. ANDERSEN S, Axelsen JB, Ringgaard S, Nyengaard JR, et al
    Effects of combined angiotensin II receptor antagonism and neprilysin inhibition in experimental pulmonary hypertension and right ventricular failure.
    Int J Cardiol. 2019 Jun 29. pii: S0167-5273(19)30876.
    PubMed     Text format     Abstract available
    
    

    
    Int J Mol Sci

13. CHENG CC, Chi PL, Shen MC, Shu CW, et al
    Caffeic Acid Phenethyl Ester Rescues Pulmonary Arterial Hypertension through the Inhibition of AKT/ERK-Dependent PDGF/HIF-1alpha In Vitro and In Vivo.
    Int J Mol Sci. 2019;20.
    PubMed     Text format     Abstract available
    
    

    
    J Am Coll Cardiol

14. MCLAUGHLIN VV, Hoeper MM, Channick RN, Chin KM, et al
    Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality.
    J Am Coll Cardiol. 2018;71:752-763.
    PubMed     Text format     Abstract available
    
    

    
    J Card Fail

15. DARDAS TF
    Pulmonary Hypertension Associated with Heart Failure: A challenge of prediction or persistence?
    J Card Fail. 2019 Jul 12. pii: S1071-9164(19)30728.
    PubMed     Text format    
    
    

    
    J Geriatr Cardiol

16. INAMPUDI C, Hemnes AR, Briasoulis A
    Approach to a patient with pulmonary hypertension.
    J Geriatr Cardiol. 2019;16:478-481.
    PubMed     Text format     Abstract available
    
    

    
    J Heart Lung Transplant

17. ARTHUR ATAAM J, Mercier O, Lamrani L, Amsallem M, et al
    ICAM-1 promotes the abnormal endothelial cell phenotype in chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2019 Jun 19. pii: S1053-2498(19)31552.
    PubMed     Text format     Abstract available
    
    

    
    J Lung Health Dis

18. STOBDAN T, Haddad GG
    Commentary: Novel Insight into the Genetic Basis of High Altitude Pulmonary Hypertension in Kyrgyz Highlanders.
    J Lung Health Dis. 2019;3:29-30.
    PubMed     Text format    
    
    

    
    J Perinatol

19. SINGH A, Feingold B, Rivera-Lebron B, Weiner D, et al
    Correlating objective echocardiographic parameters in patients with pulmonary hypertension due to bronchopulmonary dysplasia.
    J Perinatol. 2019 Jul 16. pii: 10.1038/s41372-019-0429.
    PubMed     Text format     Abstract available
    
    

    
    Kardiologiia

20. GAYNITDINOVA VV, Avdeev SN
    [Novel Biomarkers of Pulmonary Hypertension].
    Kardiologiia. 2019;59:84-94.
    PubMed     Text format     Abstract available
    
    

    
    Mediators Inflamm

21. MAEDA NY, Aiello VD, Santos PC, Thomaz AM, et al
    Relation of Macrophage Migration Inhibitory Factor to Pulmonary Hemodynamics and Vascular Structure and Carbamyl-Phosphate Synthetase I Genetic Variations in Pediatric Patients with Congenital Cardiac Shunts.
    Mediators Inflamm. 2019;2019:7305028.
    PubMed     Text format     Abstract available
    
    

    
    Medicina (Kaunas)

22. DAS BB, Jadotte MM, Chan KC
    Pulmonary Vascular Underperfusion Score in Premature Infants with Bronchopulmonary Dysplasia and Pulmonary Hypertension.
    Medicina (Kaunas). 2019;55.
    PubMed     Text format     Abstract available
    
    

    
    Mol Med Rep

23. LI Q, Zhou X, Zhou X
    Downregulation of miR98 contributes to hypoxic pulmonary hypertension by targeting ALK1.
    Mol Med Rep. 2019 Jul 9. doi: 10.3892/mmr.2019.10482.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: